𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gene expression profiling of breast cancer patients treated with docetaxel, doxorubicin, and cyclophosphamide within the GEPARTRIO trial: HER-2, but not topoisomerase II alpha and microtubule-associated protein tau, is highly predictive of tumor response

✍ Scribed by A. Rody; T. Karn; R. Gätje; A. Ahr; C. Solbach; K. Kourtis; M. Munnes; S. Loibl; S. Kissler; E. Ruckhäberle; U. Holtrich; G. von Minckwitz; M. Kaufmann


Book ID
113506819
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
146 KB
Volume
16
Category
Article
ISSN
0960-9776

No coin nor oath required. For personal study only.